Recurrence patterns after resection of liver metastases from colorectal cancer
- PMID: 25103010
- DOI: 10.1007/978-3-319-08060-4_17
Recurrence patterns after resection of liver metastases from colorectal cancer
Abstract
Recurrence of metastatic disease after resection of liver metastases from colorectal cancer remains a major problem as 70-80 % of patients will have a recurrence, most commonly in the liver or lung. To predict patterns of recurrence and outcome may guide follow-up and further treatment, as patients with recurrence might be candidates for repeated surgery or ablation therapy. A summary of studies shows that after hepatectomy 20-43 % will have a recurrence only in the remaining liver without extrahepatic disease, whereas 15-37 % will have a recurrence only to the lung. Early recurrence is associated with poorer outcome compared to late recurrence. Site of first recurrence after resection of liver metastases is predicted by several baseline variables; synchronous disease, primary tumor site, hepatic tumor size, CEA level, number of hepatic lesions, and RAS mutation status. Pattern of recurrence is a predictor for survival after hepatectomy, with liver-only and lung-only recurrences having the best survival. In the majority of patients with isolated hepatic or lung recurrence, repeated metastasectomy is possible resulting in a 40 % 5-year survival rate. Perioperative chemotherapy reduces the risk of liver recurrence after hepatectomy of colorectal cancer liver metastases.
Similar articles
-
Cohort study of the survival benefit of resection for recurrent hepatic and/or pulmonary metastases after primary hepatectomy for colorectal metastases.Ann Surg. 2010 May;251(5):902-9. doi: 10.1097/SLA.0b013e3181c9868a. Ann Surg. 2010. PMID: 20395862
-
Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma.J Am Coll Surg. 2006 Mar;202(3):468-75. doi: 10.1016/j.jamcollsurg.2005.11.008. Epub 2006 Jan 18. J Am Coll Surg. 2006. PMID: 16500252
-
[Diagnosis and treatment of colorectal liver metastases - workflow].Zentralbl Chir. 2008 Jun;133(3):267-84. doi: 10.1055/s-2008-1076796. Zentralbl Chir. 2008. PMID: 18563694 Review. German.
-
Maximal debulking liver resection as a beneficial treatment strategy for advanced and aggressive colorectal liver metastases.Anticancer Res. 2014 Oct;34(10):5547-54. Anticancer Res. 2014. PMID: 25275054
-
[Treatment strategy for hepatic metastases of colorectal cancer].Nihon Geka Gakkai Zasshi. 2003 Oct;104(10):701-6. Nihon Geka Gakkai Zasshi. 2003. PMID: 14579755 Review. Japanese.
Cited by
-
Upfront Surgery versus Neoadjuvant Perioperative Chemotherapy for Resectable Colorectal Liver Metastases: A Machine-Learning Decision Tree to Identify the Best Potential Candidates under a Parenchyma-Sparing Policy.Cancers (Basel). 2023 Jan 18;15(3):613. doi: 10.3390/cancers15030613. Cancers (Basel). 2023. PMID: 36765570 Free PMC article.
-
A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases.Ann Surg Oncol. 2023 May;30(5):2820-2827. doi: 10.1245/s10434-023-13113-2. Epub 2023 Jan 24. Ann Surg Oncol. 2023. PMID: 36692613 Free PMC article. Clinical Trial.
-
Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases: A Single-Center Review of 847 Patients.Cancers (Basel). 2022 Aug 16;14(16):3952. doi: 10.3390/cancers14163952. Cancers (Basel). 2022. PMID: 36010944 Free PMC article.
-
Artificial intelligence in the diagnosis and management of colorectal cancer liver metastases.World J Gastroenterol. 2022 Jan 7;28(1):108-122. doi: 10.3748/wjg.v28.i1.108. World J Gastroenterol. 2022. PMID: 35125822 Free PMC article. Review.
-
Identification of m6A-Related Biomarkers Associated with Prognosis of Colorectal Cancer.Med Sci Monit. 2021 Aug 10;27:e932370. doi: 10.12659/MSM.932370. Med Sci Monit. 2021. PMID: 34373442 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical